U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819254) titled 'Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors' on Jan. 27.
Brief Summary: The purpose of this study is to find out if taking a Fisetin supplement can decrease fatigue among older cancer survivors.
Study Start Date: May 01, 2025
Study Type: INTERVENTIONAL
Condition:
Fatigue
Intervention:
DRUG: Fisetin followed by Placebo
Fisetin 20 mg/kg per dose twice daily on two consecutive days for two consecutive weeks. Participants will return on day 14 for a blood draw followed by a 14-day wash-out. At the 4-week visit participants will receive a cross-over placebo-controlled dosing regimen to be taken twi...